Infectious complications in geriatric renal transplant patients: Comparison of two immunosuppressive protocols

Transplantation

Volumn 68, Issue 10, 1999, Pages 1496-1502

  Meier Kriesche, Herwig Ulf ^a   Friedman, Gary ^b   Jacobs, Martin ^b   Mulgaonkar, Shamkant ^b   Vaghela, Mahesh ^b   Kaplan, Bruce ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; FEMALE; FOLLOW UP; GERIATRICS; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

EID: 0033610699     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199911270-00012     Document Type: Article

References (14)

1. Tersigni R, Kjellstrand CM, Simmons RL, Najarian JS. Renal transplantation in high risk patients older than sixty years. Am J Surg 1976; 131: 648.
2. Wedel N, Brynger H, Blohme I. Kidney transplantation in patients 60 years and older. Scand J Urol Nephrol Suppl 1980; 54: 106.
3. Pirsch JD, Stratta RJ, Armbrust MJ, et al. Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age. Transplantation 1989; 47: 259.
4. Cantarovich D, Baatard R, Baranger T, et al. Cadaveric renal transplantation after 60 years of age: a single center experience. Transpl Int 1994; 7: 33.
5. Ismail N, Hakim RM, Helderman JH. Renal replacement therapies in the elderly. II. Renal transplantation. Am J Kidney Dis 1994; 23: 1.
6. Hestin D, Frimat L, Hubert J, Renoult E, Huu TC, Kessler M. Renal transplantation in patients over sixty years of age. Clin Nephrol 1994; 42: 232.
7. Jassal SV, Opelz G, Cole E. Transplantation in the elderly: a review. Geriatr Nephrol Urol 1997; 7: 157.
8. Nyberg G, Nilsson B, Norden G, Karlberg I. Outcome of renal transplantation in patients over the age of 60: a case-control study [see comments]. Nephrol Dial Transplant 1995; 10: 91.
9. Schaubel D, Desmeules M, Mao Y, Jeffery J, Fenton S. Survival experience among elderly end-stage renal disease patients: a controlled comparison of transplantation and dialysis. Transplantation 1995; 60: 1389.
10. Pirsch JD, Sollinger HW. Mycophenolate mofetil: clinical and experimental experience. Ther Drug Monit 1996; 18: 357.
11. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225.
12. Anonymous. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group [see comments]. Transplantation 1996; 61: 1029.
13. Halloran P, Matthew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups [published erratum appears in Transplantation 1997 Feb 27;63(4): 618]. Transplantation 1997; 63: 39.
14. Matthew TH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1998; 65: 1450.